Islet allograft rejection can be mediated by CD4+, alloantigen experienced, direct pathway T cells of TH1 and TH2 cytokine phenotype.
BACKGROUND: It is widely believed that Thl cells that secrete interferon-gamma are primarily involved in the rejection of allografts whereas Th2 cells [interleukin(IL) 4 and IL-10] are thought to be protective of this process. However, the exact role and specificity of these helper T lymphocytes in...
Main Authors: | Barbara, J, Turvey, SE, Kingsley, C, Spriewald, B, Hara, M, Witzke, O, Morris, P, Wood, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2000
|
Similar Items
-
Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection.
by: Jones, N, et al.
Published: (2001) -
Nondepleting anti-CD4 monoclonal antibody enhances the ability of oral alloantigen delivery to induce indefinite survival of cardiac allografts: oral tolerance to alloantigen.
by: Niimi, M, et al.
Published: (2000) -
Differential role for competitive reverse transcriptase-polymerase chain reaction and intracellular cytokine staining as diagnostic tools for the assessment of intragraft cytokine profiles in rejecting and nonrejecting heart allografts.
by: Spriewald, B, et al.
Published: (2000) -
Linked unresponsiveness: early cytokine gene expression profiles in cardiac allografts following pretreatment of recipients with bone marrow cells expressing donor MHC alloantigen.
by: Spriewald, B, et al.
Published: (2002) -
Cytokines and peripheral tolerance to alloantigen
by: Dallman, M, et al.
Published: (1993)